ARDXHealthcareSmall-Cap

ARDELYX, INC. Insider Trading Activity

Every SEC Form 4 insider transaction reported for ARDELYX, INC. (ARDX), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are ARDX insiders buying or selling?

ARDELYX, INC. insiders reported 20 open-market buys ($11.8M) and 260 sells ($28.8M) across 280 Form 4 filings — a net selling position of $17.0M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 17, 2026)

Total Form 4 filings
280
SEC EDGAR
Insider filers
20
Insider buys (20)
$11.8M
Insider sells (260)
$28.8M

Insider sentiment

Net selling

Net insider flow of $17.0M in net selling.

Recent ARDX insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 17, 2026Michael RaabPresident & CEOSale41.7K$5.06$210.9K
Jun 22, 2026Laura A WilliamsChief Patient OfficerSale81.9K$5.99$490.5K
Jun 17, 2026Michael RaabPresident & CEOSale41.7K$5.67$236.3K
May 22, 2026Joseph James ReillySenior Vice President and Chief Accounting OfficerSale3.7K$6.27$23.3K
May 22, 2026Susan HohenleitnerChief Financial OfficerSale1.5K$6.27$9.1K
May 22, 2026John E BishopChief Technical and Quality OfficerSale2.3K$6.27$14.5K
May 22, 2026James Parker BradyChief Human Resources OfficerSale1.8K$6.27$11.6K
May 22, 2026Eric Duane FosterChief Commercial OfficerSale8.0K$6.27$50.1K
May 22, 2026Mike KelliherChief Business OfficerSale7.2K$6.27$45.4K
May 22, 2026Laura A WilliamsChief Patient OfficerSale7.0K$6.27$43.8K
May 22, 2026Michael RaabPresident & CEOSale54.7K$6.27$343.1K
May 19, 2026Michael RaabPresident & CEOSale41.7K$6.28$261.6K
Apr 17, 2026Michael RaabPresident & CEOSale41.7K$6.29$262.0K
Mar 18, 2026Michael RaabPresident & CEOSale41.7K$5.84$243.3K
Feb 25, 2026Michael RaabPresident & CEOSale41.7K$6.26$260.6K
Feb 24, 2026David M MottDirectorPurchase333.3K$5.84$1.9M
Feb 24, 2026John E BishopChief Technical Operations OfficerSale3.2K$5.85$18.6K
Feb 24, 2026Joseph James ReillySenior Vice President and Chief Accounting OfficerSale5.0K$5.85$29.2K
Feb 24, 2026Laura A WilliamsChief Patient Officer and interim Chief Medical OfficerSale8.2K$5.85$47.8K
Feb 24, 2026Susan HohenleitnerChief Financial OfficerSale2.0K$5.85$11.9K
Feb 24, 2026James Parker BradyChief Human Resources OfficerSale2.5K$5.85$14.9K
Feb 24, 2026Mike KelliherChief Business OfficerSale9.6K$5.85$56.1K
Feb 24, 2026Michael RaabPresident & CEOSale46.0K$5.85$268.8K
Feb 24, 2026Eric Duane FosterChief Commercial OfficerSale10.4K$5.85$61.0K
Jan 9, 2026Laura A WilliamsChief Patient OfficerSale50.0K$6.98$348.9K

Showing the 25 most recent of 280 Form 4 filings for ARDELYX, INC..

Most active ARDX insiders

  • Michael Raab63 filings
  • David P. Rosenbaum38 filings
  • Elizabeth A Grammer37 filings
  • Laura A Williams24 filings
  • Justin A Renz23 filings

Ask anything about ARDX insider activity

Use Trabud's AI agent to query ARDELYX, INC.'s Form 4 history in plain English — "Show me ARDX CEO purchases this year" or compare it against any other ticker.

Open the AI agent

ARDX insider trading FAQ

Are ARDELYX, INC. insiders buying or selling?

Across 280 SEC Form 4 filings, ARDELYX, INC. (ARDX) insiders reported 20 open-market purchases totaling $11.8M and 260 sales totaling $28.8M. That is a net selling position of $17.0M.

How many insiders trade ARDX stock?

20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for ARDELYX, INC.. The most recent filing was accepted on Jul 17, 2026.

Where does Trabud get ARDX insider trading data?

All ARDX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content